181 related articles for article (PubMed ID: 9338537)
1. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.
Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J
J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537
[TBL] [Abstract][Full Text] [Related]
2. [Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study].
Tworek D; Bocheńska-Marciniak M; Kupczyk M; Kupryś-Lipińska I; Kuna P
Pneumonol Alergol Pol; 2006; 74(2):153-8. PubMed ID: 17269362
[TBL] [Abstract][Full Text] [Related]
3. New developments in the diagnosis and treatment of hymenoptera venom allergy.
Müller UR
Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
[TBL] [Abstract][Full Text] [Related]
4. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
5. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine.
Berchtold E; Maibach R; Müller U
Clin Exp Allergy; 1992 Jan; 22(1):59-65. PubMed ID: 1551035
[TBL] [Abstract][Full Text] [Related]
6. Peanut Oral Immunotherapy With or Without H
Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
[TBL] [Abstract][Full Text] [Related]
7. Insect Venom Immunotherapy: Analysis of the Safety and Tolerance of 3 Buildup Protocols Frequently Used in Spain.
Gutiérrez Fernández D; Moreno-Ancillo A; Fernández Meléndez S; Domínguez-Noche C; Gálvez Ruiz P; Alfaya Arias T; Carballada González F; Alonso Llamazares A; Marques Amat L; Vega Castro A; Antolín Amérigo D; Cruz Granados S; Ruiz León B; Sánchez Morillas L; Fernández Sánchez J; Soriano Gomis V; Borja Segade J; Dalmau Duch G; Guspi Bori R; Miranda Páez A
J Investig Allergol Clin Immunol; 2016; 26(6):366-373. PubMed ID: 27996943
[TBL] [Abstract][Full Text] [Related]
8. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial.
Reimers A; Hari Y; Müller U
Allergy; 2000 May; 55(5):484-8. PubMed ID: 10843430
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.
Paul E; Bödeker RH
Eur J Clin Pharmacol; 1986; 31(3):277-80. PubMed ID: 2878811
[TBL] [Abstract][Full Text] [Related]
10. Venom immunotherapy: adverse reactions and treatment failure.
Ruëff F; Przybilla B
Curr Opin Allergy Clin Immunol; 2004 Aug; 4(4):307-11. PubMed ID: 15238797
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic administration of histamine 1 and/or histamine 2 receptor blockers in the prevention of heparin- and protamine-related haemodynamic effects.
Kanbak M; Kahraman S; Celebioglu B; Akpolat N; Ercan S; Erdem K
Anaesth Intensive Care; 1996 Oct; 24(5):559-63. PubMed ID: 8909666
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies].
Paul E; Pfeffer M; Bödeker RH
Z Hautkr; 1987 Mar; 62(5):401-2, 405-6. PubMed ID: 2884788
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan.
Hirata H; Asakura T; Arima M; Cheng G; Honda K; Fukushima F; Yamaguchi B; Yoshida N; Fukuda T
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):89-94. PubMed ID: 14629126
[TBL] [Abstract][Full Text] [Related]
14. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone.
Sharpe GR; Shuster S
Br J Dermatol; 1993 Nov; 129(5):575-9. PubMed ID: 8251354
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
Holmberg K; Pipkorn U; Bake B; Blychert LO
Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
[TBL] [Abstract][Full Text] [Related]
16. Rapid venom immunotherapy update.
Scribner TA; Bernstein DI
Curr Opin Allergy Clin Immunol; 2003 Aug; 3(4):295-8. PubMed ID: 12865774
[TBL] [Abstract][Full Text] [Related]
17. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
[TBL] [Abstract][Full Text] [Related]
18. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
19. Specific Immunotherapy in Hymenoptera Venom Allergy and Concomitant Malignancy: A Retrospective Follow-up Focusing on Effectiveness and Safety.
Aeberhard J; Haeberli G; Müller UR; Helbling A
J Investig Allergol Clin Immunol; 2017; 27(6):370-377. PubMed ID: 28675375
[TBL] [Abstract][Full Text] [Related]
20. Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome.
Sahai J; Healy DP; Garris R; Berry A; Polk RE
J Infect Dis; 1989 Nov; 160(5):876-81. PubMed ID: 2572652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
